| GILD | Gilead Sciences Inc | 7.77% |
| VRTX | Vertex Pharmaceuticals Inc | 6.52% |
| AMGN | Amgen Inc | 6.41% |
| BIIB | Biogen Inc | 6.30% |
| REGN | Regeneron Pharmaceuticals Inc | 4.54% |
No recent news for UBIO. The ingest cron pulls every 15 minutes during market hours.
The investment seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the NASDAQ Biotechnology Index (the index). The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
ProShares UltraPro Nasdaq Biotechnology · Issued by ProShares